Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study

BACKGROUND: Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up treatment and prevention interventions. We evaluated the inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Josephine G, Kuchuloria, Tinatin, Sergeenko, David, Fraser, Hannah, Lim, Aaron G, Shadaker, Shaun, Hagan, Liesl, Gamkrelidze, Amiran, Kvaratskhelia, Valeri, Gvinjilia, Lia, Aladashvili, Malvina, Asatiani, Alexander, Baliashvili, Davit, Butsashvili, Maia, Chikovani, Ivdity, Khonelidze, Irma, Kirtadze, Irma, Kuniholm, Mark H, Otiashvili, David, Sharvadze, Lali, Stvilia, Ketevan, Tsertsvadze, Tengiz, Zakalashvili, Mamuka, Hickman, Matthew, Martin, Natasha K, Morgan, Juliette, Nasrullah, Muazzam, Averhoff, Francisco, Vickerman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025283/
https://www.ncbi.nlm.nih.gov/pubmed/31864917
http://dx.doi.org/10.1016/S2214-109X(19)30483-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025283/
https://www.ncbi.nlm.nih.gov/pubmed/31864917
http://dx.doi.org/10.1016/S2214-109X(19)30483-8

Ejemplares similares